A Project CBD Special Report on

Medical Marijuana Inc., HempMeds & Kannaway

By Aaron Miguel Cantú

October 14, 2014

Updated November 4, 2014

Project CBD Special Report: Hemp Oil Hustlers

© 2014. Project CBD. All rights reserved. 1

Forward by Project CBD

A half year ago, Project CBD assigned a writer to investigate and report on Medical Marijuana Inc., a

penny stock umbrella company that markets “hemp oil” products infused with cannabidiol (CBD), a

medicinal component of the cannabis plant. Originally we had hoped to shed light on the complex

financial machinations of Medical Marijuana Inc., a subject that had been addressed by a few stock

market analysts but not by journalists in general interest publications.

Project CBD was poised to publish Aaron Miguel Cantú’s research when we heard complaints from

several sources that people were getting sick, in some cases “violently ill,” when they ingested “Real

Scientific Hemp Oil,” Medical Marijuana Inc.’s flagship product. We decided to delay the release of

our report until we had a chance to look into whether there was any truth to these allegations.

Our investigation proceeded in an unanticipated direction, involving analytical lab tests, hemp oil

production tours, and a crash course in scientific data regarding toxic solvents, heavy metals, and

other contaminants. We have presented our findings in this report.

These findings should not be construed as justification to attack the medical marijuana community

or impose ever-more capricious restrictions on patients and providers. Nor do we wish to cast

aspersions on companies that are working with industrial hemp to create CBD-rich products. We

believe that industrial hemp is not an optimal source of CBD, but it can be a viable source of CBD

if certain hemp cultivars are grown organically in good soil and safe extraction and refinement

methods are employed.

2014 marked the first year that industrial hemp was grown legally (albeit for research purposes) in

the United States in a long time. There’s no doubt that the surge of national interest in CBD has

been a key factor in catalyzing the rebirth of industrial hemp in the United States. Project CBD

maintains that federal law should be changed to facilitate CBD production from the most prolific

natural source of cannabidiol available—CBD-rich cannabis with little THC. This would entail

legalizing the whole plant, not just a single compound or a single strain.

Project CBD wishes to acknowledge the following people who helped in various ways with this

report: James Neal-Kababick of Flora Research Laboratories, Dr. Noel Palmer of PhytaTech, Daryl

Bornhop, Jahan Marcu, Brandon Krenzler, Jason Cranford, Felicia Carbajal, Brittany Warrior,

Michael Hayes, Vanessa Waltz, Michelle Sexton, Fred Gardner, Josh Hartsel, Chris Boucher, Regina

Nelson, Angela Bacca, and Cecilia D’Anastasio and Rick Carp of the Emerging Journalist Fund.

Martin A. Lee

Director, Project CBD


omewhere in San Diego on a Friday night in February 2014, six

fidgeting men in identical white t-shirts sat clustered together on

adjacent sofas, facing a computer webcam.1 ASPIRE HIGHER,

their shirts behooved viewers.

“Can you feel it?” asked the group’s bespectacled leader, Christopher Hussey. A solemn hush fell

over the room. “It’s the calm before the storm.”

“The Kanna-storm,” added one of the other men, prompting light chuckles from his compatriots.

The group was on Google Hangout with men and women from across the country, all of whom had

come together that night to celebrate their progress in building what they called “the Kannaway

Nation.” Like a band of partisans, these men discussed how many people they’d roped into their

ranks in the last few months, marveling at their success and confidently forecasting even cheerier

prospects for the future.

Yet despite abundant use of words like “revolution,” “nation,” and “movement,” these men were

not calculating how to build the ranks of a nascent political vanguard. They were trying to recruit

more people into a multi-level marketing company called Kannaway, which relies on a loose

network of independent distributors to sell products.2 Kannaway has little infrastructure beyond a

website, PDF promotional materials, and various “hemp oil” products infused with cannabidiol

(CBD), a versatile, non-psychoactive cannabis component with exciting medical prospects.

Around the same time that the Kannaway soldiers were “aspiring higher” in their Google Hangout,

a young mother named Brittany Warrior desperately clutched her 21-month old daughter’s tiny

body, watching as her baby Jaqie writhed in pain.3 For days Jaqie’s diarrhea and vomiting would not

go away, despite a steady regimen of electrolyte-charged victuals and Pedialyte. At her wits end and

scared for her daughter’s life, Warrior finally checked Jaqie into the emergency room of a Denver


The culprit for her daughter’s illness, according to Warrior, was something called Real Scientific

Hemp Oil (RSHO) Gold, a product sold by a company called HempMedsPX.4 Warrior’s daughter is

epileptic, and according to Warrior, representatives of HempMedsPX reached out to her online and

gave her free samples of RSHO Gold, a CBD-infused product, to try on her daughter. CBD-rich oil,

a remedy of last resort for children with catastrophic seizure disorders, has proven effective in some

cases of treatment-resistant epilepsy, and HempMedsPx (since renamed HempMeds) sought to

profit from CBD’s growing reputation as a miracle compound.

What, if anything, do six guys hustling hemp oil products on Google Hangout have to do with a sick

child in Denver?

To read full report go to; http://www.projectcbd.org/wp-content/uploads/2014/10/ProjectCBD_Special-Report_Medical-Marijuana-Inc-HempMeds-Kannaway1.pdf